loading

Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten

pulisher
Jun 18, 2025

Aspire Biopharma Holdings relocates headquarters to Florida - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aspire Biopharma Relocates Executive Office to Florida - TipRanks

Jun 18, 2025
pulisher
Jun 10, 2025

Michael Howe takes helm as CEO of Aspire Biopharma By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Aspire Biopharma Holdings, Inc., Announces Michael C. HoweWith Decades of Experience at Leading and Building Brands in the Healthcare and Consumer SpaceTo Be Its New Chief Executive Officer - El Paso Times

Jun 10, 2025
pulisher
Jun 10, 2025

Aspire Biopharma Appoints New Chief Executive Officer - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Aspire Biopharma CEO Kraig Higginson Steps DownSEC Filing - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Aspire Biopharma Appoints New CEO Michael C. Howe - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Michael Howe takes helm as CEO of Aspire Biopharma - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - The Columbus Dispatch

Jun 09, 2025
pulisher
Jun 02, 2025

Aspire Biopharma (NASDAQ:ASBP) Rating Lowered to Strong Sell at Wall Street Zen - Defense World

Jun 02, 2025
pulisher
May 29, 2025

ASBP Stock Price and Chart — NASDAQ:ASBP - TradingView

May 29, 2025
pulisher
May 29, 2025

Pre-market Movers: ALZN, HCTI, REVB, NTLA... - RTTNews

May 29, 2025
pulisher
May 29, 2025

Aspire Biopharma provides development update on BUZZ BOMB supplement - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025 - Akron Beacon Journal

May 29, 2025
pulisher
May 28, 2025

Aspire Biopharma (ASPH) Stock Explodes Over 160%: What's Behind the Monumental Surge? - Daily Chhattisgarh News

May 28, 2025
pulisher
May 28, 2025

Pharma Stock Massively Bid Up Following New Product Announcement - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

Aspire Biopharma To Launch BUZZ BOMB Sublingual Pre-Workout; Begins Production And Testing - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 20, 2025

ASBP stock touches 52-week low at $0.22 amid sharp annual decline - Investing.com India

May 20, 2025
pulisher
May 20, 2025

Sidoti Events, LLC's Virtual May Micro-Cap Conference - FinancialContent

May 20, 2025
pulisher
May 19, 2025

Vita Bella Partners with New to The Street for National Media Campaign - Lohud

May 19, 2025
pulisher
May 16, 2025

Aspire Biopharma announces resale of up to 11.26M shares - MSN

May 16, 2025
pulisher
May 14, 2025

Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 08, 2025

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21 - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

ASBPAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan

May 08, 2025
pulisher
May 02, 2025

Aspire Biopharma Holdings Inc (ASBP) Stock: A Comprehensive 52-Week Review - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Was anything negative for Aspire Biopharma Holdings Inc (ASBP) stock last session? - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

Post-Trade Analysis: Aspire Biopharma Holdings Inc (ASBP) Slides -15.33, Closing at 0.36 - DWinneX

May 02, 2025
pulisher
May 01, 2025

Aspire Biopharma Settles with Lenders, Extends Loan Maturities By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
Apr 30, 2025

Aspire Biopharma Settles with Lenders, Extends Loan Maturities - Investing.com Australia

Apr 30, 2025
pulisher
Apr 29, 2025

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - The Joplin Globe

Apr 29, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 28, 2025

Former Nasdaq Private Market President Takes LogicMark's Helm: Inside the AI-Driven Healthcare Tech Transformation - Stock Titan

Apr 28, 2025
pulisher
Apr 26, 2025

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17 - ACCESS Newswire

Apr 26, 2025
$20.39
price down icon 0.34%
$36.24
price down icon 0.27%
$23.15
price up icon 7.69%
$96.83
price down icon 0.40%
$108.13
price up icon 0.15%
biotechnology ONC
$247.47
price up icon 1.13%
Kapitalisierung:     |  Volumen (24h):